Lexicon Pharmaceuticals (LXRX) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free LXRX Stock Alerts $1.58 +0.04 (+2.60%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLexicon Pharmaceuticals' (LXRX) "Hold" Rating Reaffirmed at Needham & Company LLCamericanbankingnews.com - April 24 at 4:44 AMAnalysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)markets.businessinsider.com - April 23 at 2:29 PMLexicon Pharmaceuticals (NASDAQ:LXRX) Earns Hold Rating from Needham & Company LLCmarketbeat.com - April 23 at 8:20 AMLexicon Pharmaceuticals to Host 2024 Investor Dayglobenewswire.com - April 18 at 8:00 AMLexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded to "Sell" by StockNews.commarketbeat.com - April 15 at 11:09 PMLexicon Pharmaceuticals' (LXRX) Hold Rating Reiterated at Needham & Company LLCmarketbeat.com - April 11 at 8:31 AMLexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Up 5.9%marketbeat.com - April 4 at 2:03 PMLexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 3 at 8:32 AMLexicon Pharmaceuticals (NASDAQ:LXRX) Shares Down 3.7% marketbeat.com - April 1 at 2:58 PMLexicon Pharmaceuticals (NASDAQ:LXRX) Trading Up 11.1%marketbeat.com - March 27 at 12:44 PMClinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expoglobenewswire.com - March 25 at 9:20 AMLexicon Pharmaceuticals (NASDAQ:LXRX) Trading Down 5.8%marketbeat.com - March 22 at 5:07 PMLXRX Apr 2024 5.000 putfinance.yahoo.com - March 16 at 7:59 PMLexicon Pharmaceuticals (NASDAQ:LXRX) Shares Down 6.8% marketbeat.com - March 12 at 1:24 PMLexicon Announces Positive Data Of InTandem3 Study In Type 1 Diabetes Patients With CKD; Stock Downmarkets.businessinsider.com - March 12 at 1:18 PMLexicon stock slides 8% after rallying 30% in prior sessionseekingalpha.com - March 12 at 1:18 PMNew Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Diseasefinance.yahoo.com - March 12 at 8:16 AMLexicon Pharmaceuticals: Moving To Maximize The Value Of Its Core Assetseekingalpha.com - March 12 at 4:01 AMStock Traders Purchase High Volume of Call Options on Lexicon Pharmaceuticals (NASDAQ:LXRX)marketbeat.com - March 11 at 11:31 AMLexicon Pharmaceuticals Shares Rise on Beat to 4Q Loss, Plans for Sotagliflozinmarketwatch.com - March 11 at 10:53 AMLexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDAfinance.yahoo.com - March 11 at 10:53 AMLexicon: Q4 Earnings Snapshotwashingtonpost.com - March 11 at 10:53 AMLexicon Pharmaceuticals: Q4 Earnings Insightsbenzinga.com - March 11 at 10:53 AMLexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Updateglobenewswire.com - March 11 at 7:15 AMLexicon Announces Oversubscribed $250 Million Private Placement of Equity Securitiesglobenewswire.com - March 11 at 7:05 AMFmr LLC Has $8.24 Million Stock Holdings in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)marketbeat.com - March 8 at 4:25 AMTraders Purchase High Volume of Lexicon Pharmaceuticals Call Options (NASDAQ:LXRX)marketbeat.com - February 23 at 10:39 AM15 Hot Penny Stocks On the Movefinance.yahoo.com - February 22 at 1:14 PMClariVest Asset Management LLC Sells 318,976 Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)marketbeat.com - February 21 at 9:35 AMLexicon Pharmaceuticals (NASDAQ:LXRX) Sees Strong Trading Volumemarketbeat.com - February 20 at 11:56 AMLXRX Feb 2024 5.000 putfinance.yahoo.com - February 17 at 12:16 AMLexicon Pharmaceuticals (NASDAQ:LXRX) Shares Gap Up to $2.39marketbeat.com - February 12 at 11:24 AMLexicon Pharmaceuticals (NASDAQ:LXRX) Shares Gap Up to $1.98marketbeat.com - February 2 at 11:46 AM3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analystsfool.com - January 31 at 5:14 AMLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Short Interest Updatemarketbeat.com - January 30 at 8:23 AMLexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Doseekingalpha.com - January 26 at 11:13 AMTraders Buy Large Volume of Lexicon Pharmaceuticals Call Options (NASDAQ:LXRX)marketbeat.com - January 24 at 10:37 AMLexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) largest shareholders are private equity firms with 48% ownership, institutions own 24%finance.yahoo.com - January 11 at 10:40 AMLexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 8 at 8:17 AMLexicon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:LXRX)marketbeat.com - January 5 at 11:19 AMLexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant Valueseekingalpha.com - January 4 at 5:04 PM3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Streetfool.com - December 26 at 8:04 AMLexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conferencefinance.yahoo.com - December 21 at 7:26 PMMSCLF: AAK1 Disclosed as Drug Target for DMD Program…finance.yahoo.com - December 13 at 7:05 PMThe Woodlands at 50bizjournals.com - November 24 at 7:53 AMLexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conferencefinance.yahoo.com - November 22 at 7:37 AMDirector Philippe Amouyal's Strategic 200,000 Share Purchase in Lexicon Pharmaceuticals Incfinance.yahoo.com - November 15 at 7:33 AMINPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical Datafinance.yahoo.com - November 12 at 3:43 PMLexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conferencefinance.yahoo.com - November 10 at 4:07 PMLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 10 at 10:58 AM Get Lexicon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address How a $0.25 cent option contract makes my top traders feel (Ad)If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently… Click now to see for yourself what $0.25 Cent Trades is all about LXRX Media Mentions By Week LXRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LXRX News Sentiment▼0.150.32▲Average Medical News Sentiment LXRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LXRX Articles This Week▼42▲LXRX Articles Average Week Get Lexicon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XOMA News VSTM News VNDA News RIGL News RGLS News RZLT News OPK News INVA News MNKD News IRWD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LXRX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
